Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone.

Holzapfel BM, Wagner F, Loessner D, Holzapfel NP, Thibaudeau L, Crawford R, Ling MT, Clements JA, Russell PJ, Hutmacher DW.

Biomaterials. 2014 Apr;35(13):4108-15. doi: 10.1016/j.biomaterials.2014.01.062. Epub 2014 Feb 16.

PMID:
24534484
[PubMed - in process]
2.

A tissue-engineered humanized xenograft model of human breast cancer metastasis to bone.

Thibaudeau L, Taubenberger AV, Holzapfel BM, Quent VM, Fuehrmann T, Hesami P, Brown TD, Dalton PD, Power CA, Hollier BG, Hutmacher DW.

Dis Model Mech. 2014 Feb;7(2):299-309. doi: 10.1242/dmm.014076.

PMID:
24713276
[PubMed - in process]
Free PMC Article
3.

A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone.

Hesami P, Holzapfel BM, Taubenberger A, Roudier M, Fazli L, Sieh S, Thibaudeau L, Gregory LS, Hutmacher DW, Clements JA.

Clin Exp Metastasis. 2014 Feb 8. [Epub ahead of print]

PMID:
24510218
[PubMed - as supplied by publisher]
4.

Mimicking breast cancer-induced bone metastasis in vivo: current transplantation models and advanced humanized strategies.

Thibaudeau L, Quent VM, Holzapfel BM, Taubenberger AV, Straub M, Hutmacher DW.

Cancer Metastasis Rev. 2014 Sep;33(2-3):721-35. doi: 10.1007/s10555-014-9499-z.

PMID:
24771149
[PubMed - in process]
5.

Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism.

Holzapfel BM, Thibaudeau L, Hesami P, Taubenberger A, Holzapfel NP, Mayer-Wagner S, Power C, Clements J, Russell P, Hutmacher DW.

Cancer Metastasis Rev. 2013 Jun;32(1-2):129-45. doi: 10.1007/s10555-013-9437-5. Review.

PMID:
23657538
[PubMed - indexed for MEDLINE]
6.

Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.

Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML.

Cancer Res. 1999 Apr 15;59(8):1987-93.

PMID:
10213511
[PubMed - indexed for MEDLINE]
Free Article
7.

Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.

Loessner D, Holzapfel BM, Clements JA.

Adv Drug Deliv Rev. 2014 Jun 23. pii: S0169-409X(14)00133-1. doi: 10.1016/j.addr.2014.06.001. [Epub ahead of print] Review.

PMID:
24969478
[PubMed - as supplied by publisher]
8.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
[PubMed - indexed for MEDLINE]
9.

Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment.

Reichert JC, Quent VM, Burke LJ, Stansfield SH, Clements JA, Hutmacher DW.

Biomaterials. 2010 Nov;31(31):7928-36. doi: 10.1016/j.biomaterials.2010.06.055. Epub 2010 Aug 5.

PMID:
20688384
[PubMed - indexed for MEDLINE]
10.

Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.

van der Horst G, van den Hoogen C, Buijs JT, Cheung H, Bloys H, Pelger RC, Lorenzon G, Heckmann B, Feyen J, Pujuguet P, Blanque R, Clément-Lacroix P, van der Pluijm G.

Neoplasia. 2011 Jun;13(6):516-25.

PMID:
21677875
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Animal models of bone metastasis.

Rosol TJ, Tannehill-Gregg SH, LeRoy BE, Mandl S, Contag CH.

Cancer. 2003 Feb 1;97(3 Suppl):748-57. Review.

PMID:
12548572
[PubMed - indexed for MEDLINE]
Free Article
12.

Engineering of a functional bone organ through endochondral ossification.

Scotti C, Piccinini E, Takizawa H, Todorov A, Bourgine P, Papadimitropoulos A, Barbero A, Manz MG, Martin I.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3997-4002. doi: 10.1073/pnas.1220108110. Epub 2013 Feb 11.

PMID:
23401508
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.

Nemeth JA, Yousif R, Herzog M, Che M, Upadhyay J, Shekarriz B, Bhagat S, Mullins C, Fridman R, Cher ML.

J Natl Cancer Inst. 2002 Jan 2;94(1):17-25.

PMID:
11773278
[PubMed - indexed for MEDLINE]
Free Article
14.

Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells.

Hsieh CL, Gardner TA, Miao L, Balian G, Chung LW.

Cancer Gene Ther. 2004 Feb;11(2):148-55.

PMID:
14695756
[PubMed - indexed for MEDLINE]
15.

Tissue-engineered bone serves as a target for metastasis of human breast cancer in a mouse model.

Moreau JE, Anderson K, Mauney JR, Nguyen T, Kaplan DL, Rosenblatt M.

Cancer Res. 2007 Nov 1;67(21):10304-8.

PMID:
17974972
[PubMed - indexed for MEDLINE]
Free Article
16.

The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis.

van den Hoogen C, van der Horst G, Cheung H, Buijs JT, Pelger RC, van der Pluijm G.

Clin Exp Metastasis. 2011 Oct;28(7):615-25. doi: 10.1007/s10585-011-9395-7. Epub 2011 Jun 7.

PMID:
21647815
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer.

Al Nakouzi N, Bawa O, Le Pape A, Lerondel S, Gaudin C, Opolon P, Gonin P, Fizazi K, Chauchereau A.

Neoplasia. 2012 May;14(5):376-87.

PMID:
22745584
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model.

Sieh S, Lubik AA, Clements JA, Nelson CC, Hutmacher DW.

Organogenesis. 2010 Jul-Sep;6(3):181-8.

PMID:
21197221
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.

Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Rédini F.

Bone. 2007 Apr;40(4):981-90. Epub 2006 Dec 28.

PMID:
17196895
[PubMed - indexed for MEDLINE]
20.

Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.

Bi X, Sterling JA, Merkel AR, Perrien DS, Nyman JS, Mahadevan-Jansen A.

Bone. 2013 Oct;56(2):454-60. doi: 10.1016/j.bone.2013.07.006. Epub 2013 Jul 15.

PMID:
23867219
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk